EC approves Vertex’s CF treatment Orkambi for children aged two to five years
The label extension has been granted to treat the most common form of CF based on data from a phase 3 open-label safety study in 60 patients. According
The National Medical Products Administration (NMPA) of China has approved Keymed Biosciences’ new drug application granting marketing approval for Stapokibart to treat adults with moderate-to-severe atopic dermatitis.
PCI has extended onsite controlled substance storage at its US commercial packaging locations in Philadelphia, PA and Rockford, IL, and will undertake further expansions as demand increases for
The RapidResponse platform has been selected for Novartis global TechOps organization, as part of a wider supply chain transformation initiative. RapidResponse is a cloud-based integrated supply chain planning platform,
Promentis is developing SXC-2023 along with other compounds that engage System xc-, a central nervous system target addressing glutamatergic imbalance and oxidative stress, to treat trichotillomania and other
In accordance with Zymeworks’ 2014 licensing and collaboration agreement with Lilly, Zymeworks will receive a milestone payment of US$8.0 million for Lilly’s submission of an IND application for